TY - JOUR
T1 - Meta analysis of radiofrequency ablation versus surgical resection in small and large nodule of hepatocellular carcinoma
AU - Gani, Rino A.
AU - Teressa, Maria
AU - Budiman, Refael A.
AU - Kalista, Kemal F.
AU - Lesmana, Cosmas Rinaldi A.
N1 - Publisher Copyright:
© 2024
PY - 2024
Y1 - 2024
N2 - Introduction: Although studies have indicated comparable outcomes between RFA and surgical resection in early HCC, there is still unclear evidence of benefit in larger tumor sizes. This study aimed to assess the efficacy and safety of RFA versus surgical resection in HCC patients, considering nodule size with a cutoff at 3 cm. Methods: A comprehensive search of multiple databases was conducted. The systematic review and meta-analysis followed the PRISMA guidelines. Result: Surgical resection showed superior OS (HR = 1.18, 95% CI: 1.11–1.27, p = 0.008) and RFS (HR = 1.17, 95% CI: 1.11–1.25, p < 0.00001), compared to RFA. For nodules less than 3 cm or larger than 5 cm, the OS and RFS in the surgical resection group were significantly higher than those in the RFA group, while no significant differences were observed for nodules sized 3–5 cm. However, significantly more adverse events occurred following surgical resection (OR = 0.43, 95% CI: 0.33–0.56, P < 0.00001). Conclusion: Surgical resection has better OS and RFS compared to RFA for liver tumors less than 3 cm or larger than 5 cm. For liver tumors sized 3–5 cm, RFA and surgical resection yield similar findings. RFA may become a preferable option in these 3–5 cm tumors due to its comparable efficacy and fewer adverse events for patients unsuitable for surgery.
AB - Introduction: Although studies have indicated comparable outcomes between RFA and surgical resection in early HCC, there is still unclear evidence of benefit in larger tumor sizes. This study aimed to assess the efficacy and safety of RFA versus surgical resection in HCC patients, considering nodule size with a cutoff at 3 cm. Methods: A comprehensive search of multiple databases was conducted. The systematic review and meta-analysis followed the PRISMA guidelines. Result: Surgical resection showed superior OS (HR = 1.18, 95% CI: 1.11–1.27, p = 0.008) and RFS (HR = 1.17, 95% CI: 1.11–1.25, p < 0.00001), compared to RFA. For nodules less than 3 cm or larger than 5 cm, the OS and RFS in the surgical resection group were significantly higher than those in the RFA group, while no significant differences were observed for nodules sized 3–5 cm. However, significantly more adverse events occurred following surgical resection (OR = 0.43, 95% CI: 0.33–0.56, P < 0.00001). Conclusion: Surgical resection has better OS and RFS compared to RFA for liver tumors less than 3 cm or larger than 5 cm. For liver tumors sized 3–5 cm, RFA and surgical resection yield similar findings. RFA may become a preferable option in these 3–5 cm tumors due to its comparable efficacy and fewer adverse events for patients unsuitable for surgery.
UR - http://www.scopus.com/inward/record.url?scp=85199519410&partnerID=8YFLogxK
U2 - 10.1016/j.hpb.2024.06.009
DO - 10.1016/j.hpb.2024.06.009
M3 - Review article
AN - SCOPUS:85199519410
SN - 1365-182X
VL - 26
SP - 1216
EP - 1228
JO - HPB
JF - HPB
IS - 10
ER -